Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation
Harvard University · Dana-Farber Cancer Institute · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
547
total citations
- FWCI
- 18.39
- Percentile
- 100%
- References
- 49
Citations per year
Authors
17- CMCalla M OlsonCorresponding
Harvard University, Dana-Farber Cancer Institute
- BJBaishan Jiang
Harvard University, Dana-Farber Cancer Institute
- MAMichael A. Erb
Harvard University, Dana-Farber Cancer Institute
- YLYanke Liang
Harvard University, Dana-Farber Cancer Institute
- ZMZainab M. Doctor
Harvard University, Dana-Farber Cancer Institute
Topics & keywords
Topics
Keywords
- Cereblon
- Cyclin-dependent kinase 9
- Ubiquitin ligase
- Kinase
- Chemistry
- Cell biology
- Ubiquitin
- Biology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.